Document is current
Any future updates will be listed below
-
Authors
Borchmann, Peter
Oertel, Michael
- License Information
-
More Information
Article History
Accepted: 17 March 2025
First Online: 26 May 2025
Interessenkonflikt
: P. Borchmann: Forschungsunterstützung: Takeda Oncology, MSD, Incyte. Vortragshonorare: Takeda Oncology, BMS, Roche, MSD, Miltenyi Biomedicine, Gilead, AbbVie, Incyte. Beratertätigkeit: Takeda Oncology, BMS, Roche, Miltenyi Biotec, Gilead. M. Oertel gibt an, dass kein Interessenkonflikt besteht.
Free to read: This content has been made available to all.
